Roubaix Capital’s Acutus Medical Inc AFIB Stock Holding History

Roubaix Capital’s Portfolio AFIB Stock Details AFIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-42,802	Closed	-$1.27M	–	72
2020 Q3	$1.27M	Buy	+42,802	New	+$1.3M	1.5%	36

Other funds holding AFIB

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

Roubaix Capital's AFIB Position: Q4 2020 in Review

Roubaix Capital sold out of Acutus Medical Inc (AFIB) in Q4 2020, closing a stake of 42,802 shares — an estimated $1.27M sold.

Roubaix Capital first reported a position in AFIB in Q3 2020 and held it in 1 quarter. The position peaked at $1.27M in Q3 2020. 65 funds tracked by Wall St. Rank hold AFIB as of Q4 2020.

Roubaix Capital reported no remaining Acutus Medical Inc position as of Q4 2020 after selling out during the quarter.
Roubaix Capital sold 42,802 Acutus Medical Inc shares in Q4 2020, an estimated $1.27M.
Roubaix Capital first reported a position in Acutus Medical Inc in Q3 2020 and held it in 1 quarter.
Roubaix Capital's Acutus Medical Inc position peaked at $1.27M in Q3 2020.
65 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q4 2020.

Based on Roubaix Capital's 13F filing for Q4 2020, filed 11 Feb 2021.